NASDAQ:PSNL
Personalis Inc. Stock News
$1.40
-0.0350 (-2.45%)
At Close: May 16, 2024
Personalis to Announce Third Quarter 2022 Financial Results
04:01pm, Wednesday, 19'th Oct 2022
MENLO PARK, Calif.
Tracking Cathie Wood's ARK Invest 13F Portfolio - Q3 2022 Update
07:10am, Wednesday, 19'th Oct 2022 Seeking Alpha
ARK Invest’s 13F portfolio value decreased from $16.91B to $14.35B this quarter. Click to see the firm's trades for Q3 2022.
5 Top Stocks Cathie Wood Bought This Week
05:02pm, Friday, 05'th Aug 2022
Cathie Wood's exchange-traded funds (ETFs) received a breath of fresh air this week. The ARK Innovation ETF (NYSEMKT: ARKK ) ended the period up over 12%.
Personalis, Inc. (PSNL) CEO John West on Q2 2022 Results - Earnings Call Transcript
10:45pm, Wednesday, 03'rd Aug 2022
Personalis, Inc. (NASDAQ:PSNL ) Q2 2022 Earnings Conference Call August 3, 2022 5:00 PM ET Company Participants Caroline Corner - Investor Relations John West - President & Chief Executive Officer Aar
Personalis (PSNL) Reports Q2 Loss, Tops Revenue Estimates
09:35pm, Wednesday, 03'rd Aug 2022 Zacks Investment Research
Personalis (PSNL) delivered earnings and revenue surprises of 4.76% and 21.16%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?
Personalis (PSNL) Reports Q2 Loss, Tops Revenue Estimates
06:48pm, Wednesday, 03'rd Aug 2022
Personalis (PSNL) delivered earnings and revenue surprises of 4.76% and 21.16%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?
The Prognosis For Personalis
12:41pm, Thursday, 16'th Jun 2022
Today, we profile Personalis, a small cancer genomics testing firm. The stock has taken a battering in 2022 and is posting substantial quarterly losses, but shares now sell for less than net cash.
Expert Ratings for Personalis
04:08pm, Thursday, 05'th May 2022 Benzinga
Personalis (NASDAQ:PSNL) has observed the following analyst ratings within the last quarter:
Bullish
Somewhat Bullish
Indifferent
Somewhat Bearish
Bearish
Total Ratings
4
1
0
0
0
Last 30D
2
Personalis, Inc.'s (PSNL) CEO John West on Q1 2022 Results - Earnings Call Transcript
11:44pm, Wednesday, 04'th May 2022
Personalis, Inc. (NASDAQ:PSNL ) Q1 2022 Earnings Conference Call May 4, 2022 5:00 PM ET Company Participants Caroline Corner - Investor Relations John West - President and CEO Aaron Tachibana - Chief
Personalis (PSNL) Reports Q1 Loss, Tops Revenue Estimates
10:05pm, Wednesday, 04'th May 2022 Zacks Investment Research
Personalis (PSNL) delivered earnings and revenue surprises of -10.53% and 2.61%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?
Personalis (PSNL) Reports Q1 Loss, Tops Revenue Estimates
07:33pm, Wednesday, 04'th May 2022
Personalis (PSNL) delivered earnings and revenue surprises of -10.53% and 2.61%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?
Personalis to Present Data Demonstrating Breadth of NeXT Platform for Oncology at AACR Annual Meeting 2022
09:01am, Wednesday, 23'rd Mar 2022
MENLO PARK, Calif.--(BUSINESS WIRE)--Personalis, Inc. (Nasdaq: PSNL), a leader in advanced genomics for precision oncology, announced it is presenting new data in scientific posters at the American As
Personalis Inc''s (PSNL) CEO John West on Q4 2021 Results - Earnings Call Transcript
04:05am, Friday, 25'th Feb 2022 Seeking AlphaPersonalis Inc's (PSNL) CEO John West on Q4 2021 Results - Earnings Call Transcript
11:05pm, Thursday, 24'th Feb 2022
Personalis Inc's (PSNL) CEO John West on Q4 2021 Results - Earnings Call Transcript
Personalis (PSNL) Reports Q4 Loss, Lags Revenue Estimates
11:00pm, Thursday, 24'th Feb 2022 Zacks Investment Research
Personalis (PSNL) delivered earnings and revenue surprises of 11.76% and 0.09%, respectively, for the quarter ended December 2021. Do the numbers hold clues to what lies ahead for the stock?
